← FDA Drug Approvals (Drugs@FDA)
ETRAVIRINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CARNEGIE · Approved 2022-04-13
Drug application
- FDA Application #
ANDA215402- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ETRAVIRINE
- Generic name
- ETRAVIRINE
- Active ingredients
- ETRAVIRINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CARNEGIE
- Manufacturer
- Carnegie Pharmaceuticals LLC
- First approval
- 2022-04-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown